Global Progesterone Injection Supply, Demand and Key Producers, 2026-2032
The global Progesterone Injection market size is expected to reach $ 1150 million by 2032, rising at a market growth of 4.6% CAGR during the forecast period (2026-2032).
Progesterone Injection is typically formulated as an oil-based intramuscular injection, providing systemic progesterone supplementation for the treatment of luteal phase deficiency, luteal support in assisted reproductive technology (ART) cycles, and other clinical settings requiring rapid or stable plasma progesterone levels. It represents a long-established and clinically mature dosage form with widespread historical use. Key upstream inputs include pharmaceutical-grade progesterone API (steroidal hormone), vegetable or synthetic oil vehicles, antioxidants and stabilizers, injectable glass vials, rubber stoppers and aluminum seals, as well as sterile filtration and filling consumables; material costs are relatively low, while sterile manufacturing assurance, oil-phase stability and batch-to-batch consistency are critical quality control elements. Downstream customers mainly include OB-GYN hospitals, fertility clinics, and inpatient and outpatient departments of general hospitals, with continued utilization in regions where alternative dosage forms are less accessible or adherence considerations are secondary. On a due-diligence-grade estimation basis, global nameplate capacity for Progesterone Injection in 2025 is estimated at 0.62 billion units, with actual sales of approximately 0.51 billion units. Driven by extensive generic competition and regional pricing structures, the global average ex-factory price is estimated at USD 1.6 per unit. Overall industry gross margin is estimated at approximately 41%.
The market is characterized by a mature and highly standardized landscape, with supply dominated by multi-regional generic manufacturers and broad product availability. Pricing competition is well established, and clinical use is largely confined to defined settings within obstetrics, gynecology, and reproductive medicine. In many regions, injectable progesterone remains a recognized baseline option, although prescribing decisions have become increasingly selective as treatment pathways evolve. The growing adoption of alternative dosage forms has gradually reshaped the market structure, reducing the central role of injectable therapies without eliminating their presence.
Looking forward, the market is expected to remain broadly stable or experience gradual change rather than significant expansion. Healthcare systems are increasingly prioritizing patient comfort, convenience, and adherence, which favors less invasive administration routes and limits the upside potential for injectables. Nevertheless, in clinical situations requiring rapid onset, predictable systemic exposure, or where medical resources are constrained, injectable formulations continue to offer functional advantages, preventing a sharp contraction in demand.
Key drivers include the ongoing need for reproductive health services, long-standing reliance on standardized treatment protocols, and clinical confidence in the reliability of injectable delivery in specific scenarios. In certain emerging markets and lower-tier healthcare settings, injectables remain attractive due to supply stability, clinical familiarity, and immediate therapeutic effect, providing a structural base of demand that supports market continuity.
At the same time, the market faces notable constraints. Declining patient acceptance of invasive treatments, concerns among healthcare providers regarding administration burden and safety, and tightening reimbursement and regulatory environments all exert downward pressure on usage. Moreover, continued improvements in oral and local delivery options are eroding the relative advantages of injectable therapies in some indications, resulting in a market that is structurally under pressure yet retains a degree of resilience.
This report studies the global Progesterone Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Progesterone Injection and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Progesterone Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Progesterone Injection total production and demand, 2021-2032, (K Units)
Global Progesterone Injection total production value, 2021-2032, (USD Million)
Global Progesterone Injection production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Progesterone Injection consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Progesterone Injection domestic production, consumption, key domestic manufacturers and share
Global Progesterone Injection production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Progesterone Injection production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Progesterone Injection production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Progesterone Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Besins Healthcare, Organon, Pfizer, Sun Pharmaceutical Industries, Zydus Lifesciences, Cipla, Intas Pharmaceuticals, Zhejiang Xianju Pharmaceutical, Grand Pharmaceutical Group, Livzon, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Progesterone Injection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Progesterone Injection Market, By Region:
1. How big is the global Progesterone Injection market?
2. What is the demand of the global Progesterone Injection market?
3. What is the year over year growth of the global Progesterone Injection market?
4. What is the production and production value of the global Progesterone Injection market?
5. Who are the key producers in the global Progesterone Injection market?
6. What are the growth factors driving the market demand?
Progesterone Injection is typically formulated as an oil-based intramuscular injection, providing systemic progesterone supplementation for the treatment of luteal phase deficiency, luteal support in assisted reproductive technology (ART) cycles, and other clinical settings requiring rapid or stable plasma progesterone levels. It represents a long-established and clinically mature dosage form with widespread historical use. Key upstream inputs include pharmaceutical-grade progesterone API (steroidal hormone), vegetable or synthetic oil vehicles, antioxidants and stabilizers, injectable glass vials, rubber stoppers and aluminum seals, as well as sterile filtration and filling consumables; material costs are relatively low, while sterile manufacturing assurance, oil-phase stability and batch-to-batch consistency are critical quality control elements. Downstream customers mainly include OB-GYN hospitals, fertility clinics, and inpatient and outpatient departments of general hospitals, with continued utilization in regions where alternative dosage forms are less accessible or adherence considerations are secondary. On a due-diligence-grade estimation basis, global nameplate capacity for Progesterone Injection in 2025 is estimated at 0.62 billion units, with actual sales of approximately 0.51 billion units. Driven by extensive generic competition and regional pricing structures, the global average ex-factory price is estimated at USD 1.6 per unit. Overall industry gross margin is estimated at approximately 41%.
The market is characterized by a mature and highly standardized landscape, with supply dominated by multi-regional generic manufacturers and broad product availability. Pricing competition is well established, and clinical use is largely confined to defined settings within obstetrics, gynecology, and reproductive medicine. In many regions, injectable progesterone remains a recognized baseline option, although prescribing decisions have become increasingly selective as treatment pathways evolve. The growing adoption of alternative dosage forms has gradually reshaped the market structure, reducing the central role of injectable therapies without eliminating their presence.
Looking forward, the market is expected to remain broadly stable or experience gradual change rather than significant expansion. Healthcare systems are increasingly prioritizing patient comfort, convenience, and adherence, which favors less invasive administration routes and limits the upside potential for injectables. Nevertheless, in clinical situations requiring rapid onset, predictable systemic exposure, or where medical resources are constrained, injectable formulations continue to offer functional advantages, preventing a sharp contraction in demand.
Key drivers include the ongoing need for reproductive health services, long-standing reliance on standardized treatment protocols, and clinical confidence in the reliability of injectable delivery in specific scenarios. In certain emerging markets and lower-tier healthcare settings, injectables remain attractive due to supply stability, clinical familiarity, and immediate therapeutic effect, providing a structural base of demand that supports market continuity.
At the same time, the market faces notable constraints. Declining patient acceptance of invasive treatments, concerns among healthcare providers regarding administration burden and safety, and tightening reimbursement and regulatory environments all exert downward pressure on usage. Moreover, continued improvements in oral and local delivery options are eroding the relative advantages of injectable therapies in some indications, resulting in a market that is structurally under pressure yet retains a degree of resilience.
This report studies the global Progesterone Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Progesterone Injection and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Progesterone Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Progesterone Injection total production and demand, 2021-2032, (K Units)
Global Progesterone Injection total production value, 2021-2032, (USD Million)
Global Progesterone Injection production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Progesterone Injection consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Progesterone Injection domestic production, consumption, key domestic manufacturers and share
Global Progesterone Injection production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Progesterone Injection production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Progesterone Injection production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Progesterone Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Besins Healthcare, Organon, Pfizer, Sun Pharmaceutical Industries, Zydus Lifesciences, Cipla, Intas Pharmaceuticals, Zhejiang Xianju Pharmaceutical, Grand Pharmaceutical Group, Livzon, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Progesterone Injection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Progesterone Injection Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Originator Products
- Branded Generics
- Oil-based Intramuscular Injection
- Other
- Luteal Phase Support in Assisted Reproductive Technology
- Treatment of Luteal Phase Deficiency
- Others
- Hospital
- Clinic
- Others
- Besins Healthcare
- Organon
- Pfizer
- Sun Pharmaceutical Industries
- Zydus Lifesciences
- Cipla
- Intas Pharmaceuticals
- Zhejiang Xianju Pharmaceutical
- Grand Pharmaceutical Group
- Livzon
1. How big is the global Progesterone Injection market?
2. What is the demand of the global Progesterone Injection market?
3. What is the year over year growth of the global Progesterone Injection market?
4. What is the production and production value of the global Progesterone Injection market?
5. Who are the key producers in the global Progesterone Injection market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Progesterone Injection Introduction
1.2 World Progesterone Injection Supply & Forecast
1.2.1 World Progesterone Injection Production Value (2021 & 2025 & 2032)
1.2.2 World Progesterone Injection Production (2021-2032)
1.2.3 World Progesterone Injection Pricing Trends (2021-2032)
1.3 World Progesterone Injection Production by Region (Based on Production Site)
1.3.1 World Progesterone Injection Production Value by Region (2021-2032)
1.3.2 World Progesterone Injection Production by Region (2021-2032)
1.3.3 World Progesterone Injection Average Price by Region (2021-2032)
1.3.4 North America Progesterone Injection Production (2021-2032)
1.3.5 Europe Progesterone Injection Production (2021-2032)
1.3.6 China Progesterone Injection Production (2021-2032)
1.3.7 Japan Progesterone Injection Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Progesterone Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Progesterone Injection Major Market Trends
2 DEMAND SUMMARY
2.1 World Progesterone Injection Demand (2021-2032)
2.2 World Progesterone Injection Consumption by Region
2.2.1 World Progesterone Injection Consumption by Region (2021-2026)
2.2.2 World Progesterone Injection Consumption Forecast by Region (2027-2032)
2.3 United States Progesterone Injection Consumption (2021-2032)
2.4 China Progesterone Injection Consumption (2021-2032)
2.5 Europe Progesterone Injection Consumption (2021-2032)
2.6 Japan Progesterone Injection Consumption (2021-2032)
2.7 South Korea Progesterone Injection Consumption (2021-2032)
2.8 ASEAN Progesterone Injection Consumption (2021-2032)
2.9 India Progesterone Injection Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Progesterone Injection Production Value by Manufacturer (2021-2026)
3.2 World Progesterone Injection Production by Manufacturer (2021-2026)
3.3 World Progesterone Injection Average Price by Manufacturer (2021-2026)
3.4 Progesterone Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Progesterone Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Progesterone Injection in 2025
3.5.3 Global Concentration Ratios (CR8) for Progesterone Injection in 2025
3.6 Progesterone Injection Market: Overall Company Footprint Analysis
3.6.1 Progesterone Injection Market: Region Footprint
3.6.2 Progesterone Injection Market: Company Product Type Footprint
3.6.3 Progesterone Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Progesterone Injection Production Value Comparison
4.1.1 United States VS China: Progesterone Injection Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Progesterone Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Progesterone Injection Production Comparison
4.2.1 United States VS China: Progesterone Injection Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Progesterone Injection Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Progesterone Injection Consumption Comparison
4.3.1 United States VS China: Progesterone Injection Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Progesterone Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Progesterone Injection Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Progesterone Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Progesterone Injection Production Value (2021-2026)
4.4.3 United States Based Manufacturers Progesterone Injection Production (2021-2026)
4.5 China Based Progesterone Injection Manufacturers and Market Share
4.5.1 China Based Progesterone Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Progesterone Injection Production Value (2021-2026)
4.5.3 China Based Manufacturers Progesterone Injection Production (2021-2026)
4.6 Rest of World Based Progesterone Injection Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Progesterone Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Progesterone Injection Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Progesterone Injection Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Progesterone Injection Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Originator Products
5.2.2 Branded Generics
5.3 Market Segment by Type
5.3.1 World Progesterone Injection Production by Type (2021-2032)
5.3.2 World Progesterone Injection Production Value by Type (2021-2032)
5.3.3 World Progesterone Injection Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY FORMULATION
6.1 World Progesterone Injection Market Size Overview by Formulation: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Formulation
6.2.1 Oil-based Intramuscular Injection
6.2.2 Other
6.3 Market Segment by Formulation
6.3.1 World Progesterone Injection Production by Formulation (2021-2032)
6.3.2 World Progesterone Injection Production Value by Formulation (2021-2032)
6.3.3 World Progesterone Injection Average Price by Formulation (2021-2032)
7 MARKET ANALYSIS BY CLINICAL INDICATION
7.1 World Progesterone Injection Market Size Overview by Clinical Indication: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Clinical Indication
7.2.1 Luteal Phase Support in Assisted Reproductive Technology
7.2.2 Treatment of Luteal Phase Deficiency
7.2.3 Others
7.3 Market Segment by Clinical Indication
7.3.1 World Progesterone Injection Production by Clinical Indication (2021-2032)
7.3.2 World Progesterone Injection Production Value by Clinical Indication (2021-2032)
7.3.3 World Progesterone Injection Average Price by Clinical Indication (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Progesterone Injection Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Progesterone Injection Production by Application (2021-2032)
8.3.2 World Progesterone Injection Production Value by Application (2021-2032)
8.3.3 World Progesterone Injection Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Besins Healthcare
9.1.1 Besins Healthcare Details
9.1.2 Besins Healthcare Major Business
9.1.3 Besins Healthcare Progesterone Injection Product and Services
9.1.4 Besins Healthcare Progesterone Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Besins Healthcare Recent Developments/Updates
9.1.6 Besins Healthcare Competitive Strengths & Weaknesses
9.2 Organon
9.2.1 Organon Details
9.2.2 Organon Major Business
9.2.3 Organon Progesterone Injection Product and Services
9.2.4 Organon Progesterone Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Organon Recent Developments/Updates
9.2.6 Organon Competitive Strengths & Weaknesses
9.3 Pfizer
9.3.1 Pfizer Details
9.3.2 Pfizer Major Business
9.3.3 Pfizer Progesterone Injection Product and Services
9.3.4 Pfizer Progesterone Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Pfizer Recent Developments/Updates
9.3.6 Pfizer Competitive Strengths & Weaknesses
9.4 Sun Pharmaceutical Industries
9.4.1 Sun Pharmaceutical Industries Details
9.4.2 Sun Pharmaceutical Industries Major Business
9.4.3 Sun Pharmaceutical Industries Progesterone Injection Product and Services
9.4.4 Sun Pharmaceutical Industries Progesterone Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Sun Pharmaceutical Industries Recent Developments/Updates
9.4.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
9.5 Zydus Lifesciences
9.5.1 Zydus Lifesciences Details
9.5.2 Zydus Lifesciences Major Business
9.5.3 Zydus Lifesciences Progesterone Injection Product and Services
9.5.4 Zydus Lifesciences Progesterone Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Zydus Lifesciences Recent Developments/Updates
9.5.6 Zydus Lifesciences Competitive Strengths & Weaknesses
9.6 Cipla
9.6.1 Cipla Details
9.6.2 Cipla Major Business
9.6.3 Cipla Progesterone Injection Product and Services
9.6.4 Cipla Progesterone Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Cipla Recent Developments/Updates
9.6.6 Cipla Competitive Strengths & Weaknesses
9.7 Intas Pharmaceuticals
9.7.1 Intas Pharmaceuticals Details
9.7.2 Intas Pharmaceuticals Major Business
9.7.3 Intas Pharmaceuticals Progesterone Injection Product and Services
9.7.4 Intas Pharmaceuticals Progesterone Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Intas Pharmaceuticals Recent Developments/Updates
9.7.6 Intas Pharmaceuticals Competitive Strengths & Weaknesses
9.8 Zhejiang Xianju Pharmaceutical
9.8.1 Zhejiang Xianju Pharmaceutical Details
9.8.2 Zhejiang Xianju Pharmaceutical Major Business
9.8.3 Zhejiang Xianju Pharmaceutical Progesterone Injection Product and Services
9.8.4 Zhejiang Xianju Pharmaceutical Progesterone Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
9.8.6 Zhejiang Xianju Pharmaceutical Competitive Strengths & Weaknesses
9.9 Grand Pharmaceutical Group
9.9.1 Grand Pharmaceutical Group Details
9.9.2 Grand Pharmaceutical Group Major Business
9.9.3 Grand Pharmaceutical Group Progesterone Injection Product and Services
9.9.4 Grand Pharmaceutical Group Progesterone Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Grand Pharmaceutical Group Recent Developments/Updates
9.9.6 Grand Pharmaceutical Group Competitive Strengths & Weaknesses
9.10 Livzon
9.10.1 Livzon Details
9.10.2 Livzon Major Business
9.10.3 Livzon Progesterone Injection Product and Services
9.10.4 Livzon Progesterone Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Livzon Recent Developments/Updates
9.10.6 Livzon Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Progesterone Injection Industry Chain
10.2 Progesterone Injection Upstream Analysis
10.2.1 Progesterone Injection Core Raw Materials
10.2.2 Main Manufacturers of Progesterone Injection Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Progesterone Injection Production Mode
10.6 Progesterone Injection Procurement Model
10.7 Progesterone Injection Industry Sales Model and Sales Channels
10.7.1 Progesterone Injection Sales Model
10.7.2 Progesterone Injection Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Progesterone Injection Introduction
1.2 World Progesterone Injection Supply & Forecast
1.2.1 World Progesterone Injection Production Value (2021 & 2025 & 2032)
1.2.2 World Progesterone Injection Production (2021-2032)
1.2.3 World Progesterone Injection Pricing Trends (2021-2032)
1.3 World Progesterone Injection Production by Region (Based on Production Site)
1.3.1 World Progesterone Injection Production Value by Region (2021-2032)
1.3.2 World Progesterone Injection Production by Region (2021-2032)
1.3.3 World Progesterone Injection Average Price by Region (2021-2032)
1.3.4 North America Progesterone Injection Production (2021-2032)
1.3.5 Europe Progesterone Injection Production (2021-2032)
1.3.6 China Progesterone Injection Production (2021-2032)
1.3.7 Japan Progesterone Injection Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Progesterone Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Progesterone Injection Major Market Trends
2 DEMAND SUMMARY
2.1 World Progesterone Injection Demand (2021-2032)
2.2 World Progesterone Injection Consumption by Region
2.2.1 World Progesterone Injection Consumption by Region (2021-2026)
2.2.2 World Progesterone Injection Consumption Forecast by Region (2027-2032)
2.3 United States Progesterone Injection Consumption (2021-2032)
2.4 China Progesterone Injection Consumption (2021-2032)
2.5 Europe Progesterone Injection Consumption (2021-2032)
2.6 Japan Progesterone Injection Consumption (2021-2032)
2.7 South Korea Progesterone Injection Consumption (2021-2032)
2.8 ASEAN Progesterone Injection Consumption (2021-2032)
2.9 India Progesterone Injection Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Progesterone Injection Production Value by Manufacturer (2021-2026)
3.2 World Progesterone Injection Production by Manufacturer (2021-2026)
3.3 World Progesterone Injection Average Price by Manufacturer (2021-2026)
3.4 Progesterone Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Progesterone Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Progesterone Injection in 2025
3.5.3 Global Concentration Ratios (CR8) for Progesterone Injection in 2025
3.6 Progesterone Injection Market: Overall Company Footprint Analysis
3.6.1 Progesterone Injection Market: Region Footprint
3.6.2 Progesterone Injection Market: Company Product Type Footprint
3.6.3 Progesterone Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Progesterone Injection Production Value Comparison
4.1.1 United States VS China: Progesterone Injection Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Progesterone Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Progesterone Injection Production Comparison
4.2.1 United States VS China: Progesterone Injection Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Progesterone Injection Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Progesterone Injection Consumption Comparison
4.3.1 United States VS China: Progesterone Injection Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Progesterone Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Progesterone Injection Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Progesterone Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Progesterone Injection Production Value (2021-2026)
4.4.3 United States Based Manufacturers Progesterone Injection Production (2021-2026)
4.5 China Based Progesterone Injection Manufacturers and Market Share
4.5.1 China Based Progesterone Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Progesterone Injection Production Value (2021-2026)
4.5.3 China Based Manufacturers Progesterone Injection Production (2021-2026)
4.6 Rest of World Based Progesterone Injection Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Progesterone Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Progesterone Injection Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Progesterone Injection Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Progesterone Injection Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Originator Products
5.2.2 Branded Generics
5.3 Market Segment by Type
5.3.1 World Progesterone Injection Production by Type (2021-2032)
5.3.2 World Progesterone Injection Production Value by Type (2021-2032)
5.3.3 World Progesterone Injection Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY FORMULATION
6.1 World Progesterone Injection Market Size Overview by Formulation: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Formulation
6.2.1 Oil-based Intramuscular Injection
6.2.2 Other
6.3 Market Segment by Formulation
6.3.1 World Progesterone Injection Production by Formulation (2021-2032)
6.3.2 World Progesterone Injection Production Value by Formulation (2021-2032)
6.3.3 World Progesterone Injection Average Price by Formulation (2021-2032)
7 MARKET ANALYSIS BY CLINICAL INDICATION
7.1 World Progesterone Injection Market Size Overview by Clinical Indication: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Clinical Indication
7.2.1 Luteal Phase Support in Assisted Reproductive Technology
7.2.2 Treatment of Luteal Phase Deficiency
7.2.3 Others
7.3 Market Segment by Clinical Indication
7.3.1 World Progesterone Injection Production by Clinical Indication (2021-2032)
7.3.2 World Progesterone Injection Production Value by Clinical Indication (2021-2032)
7.3.3 World Progesterone Injection Average Price by Clinical Indication (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Progesterone Injection Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Progesterone Injection Production by Application (2021-2032)
8.3.2 World Progesterone Injection Production Value by Application (2021-2032)
8.3.3 World Progesterone Injection Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Besins Healthcare
9.1.1 Besins Healthcare Details
9.1.2 Besins Healthcare Major Business
9.1.3 Besins Healthcare Progesterone Injection Product and Services
9.1.4 Besins Healthcare Progesterone Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Besins Healthcare Recent Developments/Updates
9.1.6 Besins Healthcare Competitive Strengths & Weaknesses
9.2 Organon
9.2.1 Organon Details
9.2.2 Organon Major Business
9.2.3 Organon Progesterone Injection Product and Services
9.2.4 Organon Progesterone Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Organon Recent Developments/Updates
9.2.6 Organon Competitive Strengths & Weaknesses
9.3 Pfizer
9.3.1 Pfizer Details
9.3.2 Pfizer Major Business
9.3.3 Pfizer Progesterone Injection Product and Services
9.3.4 Pfizer Progesterone Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Pfizer Recent Developments/Updates
9.3.6 Pfizer Competitive Strengths & Weaknesses
9.4 Sun Pharmaceutical Industries
9.4.1 Sun Pharmaceutical Industries Details
9.4.2 Sun Pharmaceutical Industries Major Business
9.4.3 Sun Pharmaceutical Industries Progesterone Injection Product and Services
9.4.4 Sun Pharmaceutical Industries Progesterone Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Sun Pharmaceutical Industries Recent Developments/Updates
9.4.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
9.5 Zydus Lifesciences
9.5.1 Zydus Lifesciences Details
9.5.2 Zydus Lifesciences Major Business
9.5.3 Zydus Lifesciences Progesterone Injection Product and Services
9.5.4 Zydus Lifesciences Progesterone Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Zydus Lifesciences Recent Developments/Updates
9.5.6 Zydus Lifesciences Competitive Strengths & Weaknesses
9.6 Cipla
9.6.1 Cipla Details
9.6.2 Cipla Major Business
9.6.3 Cipla Progesterone Injection Product and Services
9.6.4 Cipla Progesterone Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Cipla Recent Developments/Updates
9.6.6 Cipla Competitive Strengths & Weaknesses
9.7 Intas Pharmaceuticals
9.7.1 Intas Pharmaceuticals Details
9.7.2 Intas Pharmaceuticals Major Business
9.7.3 Intas Pharmaceuticals Progesterone Injection Product and Services
9.7.4 Intas Pharmaceuticals Progesterone Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Intas Pharmaceuticals Recent Developments/Updates
9.7.6 Intas Pharmaceuticals Competitive Strengths & Weaknesses
9.8 Zhejiang Xianju Pharmaceutical
9.8.1 Zhejiang Xianju Pharmaceutical Details
9.8.2 Zhejiang Xianju Pharmaceutical Major Business
9.8.3 Zhejiang Xianju Pharmaceutical Progesterone Injection Product and Services
9.8.4 Zhejiang Xianju Pharmaceutical Progesterone Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
9.8.6 Zhejiang Xianju Pharmaceutical Competitive Strengths & Weaknesses
9.9 Grand Pharmaceutical Group
9.9.1 Grand Pharmaceutical Group Details
9.9.2 Grand Pharmaceutical Group Major Business
9.9.3 Grand Pharmaceutical Group Progesterone Injection Product and Services
9.9.4 Grand Pharmaceutical Group Progesterone Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Grand Pharmaceutical Group Recent Developments/Updates
9.9.6 Grand Pharmaceutical Group Competitive Strengths & Weaknesses
9.10 Livzon
9.10.1 Livzon Details
9.10.2 Livzon Major Business
9.10.3 Livzon Progesterone Injection Product and Services
9.10.4 Livzon Progesterone Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Livzon Recent Developments/Updates
9.10.6 Livzon Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Progesterone Injection Industry Chain
10.2 Progesterone Injection Upstream Analysis
10.2.1 Progesterone Injection Core Raw Materials
10.2.2 Main Manufacturers of Progesterone Injection Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Progesterone Injection Production Mode
10.6 Progesterone Injection Procurement Model
10.7 Progesterone Injection Industry Sales Model and Sales Channels
10.7.1 Progesterone Injection Sales Model
10.7.2 Progesterone Injection Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Progesterone Injection Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Progesterone Injection Production Value by Region (2021-2026) & (USD Million)
Table 3. World Progesterone Injection Production Value by Region (2027-2032) & (USD Million)
Table 4. World Progesterone Injection Production Value Market Share by Region (2021-2026)
Table 5. World Progesterone Injection Production Value Market Share by Region (2027-2032)
Table 6. World Progesterone Injection Production by Region (2021-2026) & (K Units)
Table 7. World Progesterone Injection Production by Region (2027-2032) & (K Units)
Table 8. World Progesterone Injection Production Market Share by Region (2021-2026)
Table 9. World Progesterone Injection Production Market Share by Region (2027-2032)
Table 10. World Progesterone Injection Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Progesterone Injection Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Progesterone Injection Major Market Trends
Table 13. World Progesterone Injection Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Progesterone Injection Consumption by Region (2021-2026) & (K Units)
Table 15. World Progesterone Injection Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Progesterone Injection Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Progesterone Injection Producers in 2025
Table 18. World Progesterone Injection Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Progesterone Injection Producers in 2025
Table 20. World Progesterone Injection Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Progesterone Injection Company Evaluation Quadrant
Table 22. World Progesterone Injection Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Progesterone Injection Production Site of Key Manufacturer
Table 24. Progesterone Injection Market: Company Product Type Footprint
Table 25. Progesterone Injection Market: Company Product Application Footprint
Table 26. Progesterone Injection Competitive Factors
Table 27. Progesterone Injection New Entrant and Capacity Expansion Plans
Table 28. Progesterone Injection Mergers & Acquisitions Activity
Table 29. United States VS China Progesterone Injection Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Progesterone Injection Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Progesterone Injection Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Progesterone Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Progesterone Injection Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Progesterone Injection Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Progesterone Injection Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Progesterone Injection Production Market Share (2021-2026)
Table 37. China Based Progesterone Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Progesterone Injection Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Progesterone Injection Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Progesterone Injection Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Progesterone Injection Production Market Share (2021-2026)
Table 42. Rest of World Based Progesterone Injection Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Progesterone Injection Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Progesterone Injection Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Progesterone Injection Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Progesterone Injection Production Market Share (2021-2026)
Table 47. World Progesterone Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Progesterone Injection Production by Type (2021-2026) & (K Units)
Table 49. World Progesterone Injection Production by Type (2027-2032) & (K Units)
Table 50. World Progesterone Injection Production Value by Type (2021-2026) & (USD Million)
Table 51. World Progesterone Injection Production Value by Type (2027-2032) & (USD Million)
Table 52. World Progesterone Injection Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Progesterone Injection Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Progesterone Injection Production Value by Formulation, (USD Million), 2021 & 2025 & 2032
Table 55. World Progesterone Injection Production by Formulation (2021-2026) & (K Units)
Table 56. World Progesterone Injection Production by Formulation (2027-2032) & (K Units)
Table 57. World Progesterone Injection Production Value by Formulation (2021-2026) & (USD Million)
Table 58. World Progesterone Injection Production Value by Formulation (2027-2032) & (USD Million)
Table 59. World Progesterone Injection Average Price by Formulation (2021-2026) & (US$/Unit)
Table 60. World Progesterone Injection Average Price by Formulation (2027-2032) & (US$/Unit)
Table 61. World Progesterone Injection Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Table 62. World Progesterone Injection Production by Clinical Indication (2021-2026) & (K Units)
Table 63. World Progesterone Injection Production by Clinical Indication (2027-2032) & (K Units)
Table 64. World Progesterone Injection Production Value by Clinical Indication (2021-2026) & (USD Million)
Table 65. World Progesterone Injection Production Value by Clinical Indication (2027-2032) & (USD Million)
Table 66. World Progesterone Injection Average Price by Clinical Indication (2021-2026) & (US$/Unit)
Table 67. World Progesterone Injection Average Price by Clinical Indication (2027-2032) & (US$/Unit)
Table 68. World Progesterone Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Progesterone Injection Production by Application (2021-2026) & (K Units)
Table 70. World Progesterone Injection Production by Application (2027-2032) & (K Units)
Table 71. World Progesterone Injection Production Value by Application (2021-2026) & (USD Million)
Table 72. World Progesterone Injection Production Value by Application (2027-2032) & (USD Million)
Table 73. World Progesterone Injection Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Progesterone Injection Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Besins Healthcare Basic Information, Manufacturing Base and Competitors
Table 76. Besins Healthcare Major Business
Table 77. Besins Healthcare Progesterone Injection Product and Services
Table 78. Besins Healthcare Progesterone Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Besins Healthcare Recent Developments/Updates
Table 80. Besins Healthcare Competitive Strengths & Weaknesses
Table 81. Organon Basic Information, Manufacturing Base and Competitors
Table 82. Organon Major Business
Table 83. Organon Progesterone Injection Product and Services
Table 84. Organon Progesterone Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Organon Recent Developments/Updates
Table 86. Organon Competitive Strengths & Weaknesses
Table 87. Pfizer Basic Information, Manufacturing Base and Competitors
Table 88. Pfizer Major Business
Table 89. Pfizer Progesterone Injection Product and Services
Table 90. Pfizer Progesterone Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Pfizer Recent Developments/Updates
Table 92. Pfizer Competitive Strengths & Weaknesses
Table 93. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 94. Sun Pharmaceutical Industries Major Business
Table 95. Sun Pharmaceutical Industries Progesterone Injection Product and Services
Table 96. Sun Pharmaceutical Industries Progesterone Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Sun Pharmaceutical Industries Recent Developments/Updates
Table 98. Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 99. Zydus Lifesciences Basic Information, Manufacturing Base and Competitors
Table 100. Zydus Lifesciences Major Business
Table 101. Zydus Lifesciences Progesterone Injection Product and Services
Table 102. Zydus Lifesciences Progesterone Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Zydus Lifesciences Recent Developments/Updates
Table 104. Zydus Lifesciences Competitive Strengths & Weaknesses
Table 105. Cipla Basic Information, Manufacturing Base and Competitors
Table 106. Cipla Major Business
Table 107. Cipla Progesterone Injection Product and Services
Table 108. Cipla Progesterone Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Cipla Recent Developments/Updates
Table 110. Cipla Competitive Strengths & Weaknesses
Table 111. Intas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 112. Intas Pharmaceuticals Major Business
Table 113. Intas Pharmaceuticals Progesterone Injection Product and Services
Table 114. Intas Pharmaceuticals Progesterone Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Intas Pharmaceuticals Recent Developments/Updates
Table 116. Intas Pharmaceuticals Competitive Strengths & Weaknesses
Table 117. Zhejiang Xianju Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 118. Zhejiang Xianju Pharmaceutical Major Business
Table 119. Zhejiang Xianju Pharmaceutical Progesterone Injection Product and Services
Table 120. Zhejiang Xianju Pharmaceutical Progesterone Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Zhejiang Xianju Pharmaceutical Recent Developments/Updates
Table 122. Zhejiang Xianju Pharmaceutical Competitive Strengths & Weaknesses
Table 123. Grand Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 124. Grand Pharmaceutical Group Major Business
Table 125. Grand Pharmaceutical Group Progesterone Injection Product and Services
Table 126. Grand Pharmaceutical Group Progesterone Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Grand Pharmaceutical Group Recent Developments/Updates
Table 128. Grand Pharmaceutical Group Competitive Strengths & Weaknesses
Table 129. Livzon Basic Information, Manufacturing Base and Competitors
Table 130. Livzon Major Business
Table 131. Livzon Progesterone Injection Product and Services
Table 132. Livzon Progesterone Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Livzon Recent Developments/Updates
Table 134. Livzon Competitive Strengths & Weaknesses
Table 135. Global Key Players of Progesterone Injection Upstream (Raw Materials)
Table 136. Global Progesterone Injection Typical Customers
Table 137. Progesterone Injection Typical Distributors
Table 1. World Progesterone Injection Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Progesterone Injection Production Value by Region (2021-2026) & (USD Million)
Table 3. World Progesterone Injection Production Value by Region (2027-2032) & (USD Million)
Table 4. World Progesterone Injection Production Value Market Share by Region (2021-2026)
Table 5. World Progesterone Injection Production Value Market Share by Region (2027-2032)
Table 6. World Progesterone Injection Production by Region (2021-2026) & (K Units)
Table 7. World Progesterone Injection Production by Region (2027-2032) & (K Units)
Table 8. World Progesterone Injection Production Market Share by Region (2021-2026)
Table 9. World Progesterone Injection Production Market Share by Region (2027-2032)
Table 10. World Progesterone Injection Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Progesterone Injection Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Progesterone Injection Major Market Trends
Table 13. World Progesterone Injection Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Progesterone Injection Consumption by Region (2021-2026) & (K Units)
Table 15. World Progesterone Injection Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Progesterone Injection Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Progesterone Injection Producers in 2025
Table 18. World Progesterone Injection Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Progesterone Injection Producers in 2025
Table 20. World Progesterone Injection Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Progesterone Injection Company Evaluation Quadrant
Table 22. World Progesterone Injection Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Progesterone Injection Production Site of Key Manufacturer
Table 24. Progesterone Injection Market: Company Product Type Footprint
Table 25. Progesterone Injection Market: Company Product Application Footprint
Table 26. Progesterone Injection Competitive Factors
Table 27. Progesterone Injection New Entrant and Capacity Expansion Plans
Table 28. Progesterone Injection Mergers & Acquisitions Activity
Table 29. United States VS China Progesterone Injection Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Progesterone Injection Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Progesterone Injection Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Progesterone Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Progesterone Injection Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Progesterone Injection Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Progesterone Injection Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Progesterone Injection Production Market Share (2021-2026)
Table 37. China Based Progesterone Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Progesterone Injection Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Progesterone Injection Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Progesterone Injection Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Progesterone Injection Production Market Share (2021-2026)
Table 42. Rest of World Based Progesterone Injection Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Progesterone Injection Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Progesterone Injection Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Progesterone Injection Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Progesterone Injection Production Market Share (2021-2026)
Table 47. World Progesterone Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Progesterone Injection Production by Type (2021-2026) & (K Units)
Table 49. World Progesterone Injection Production by Type (2027-2032) & (K Units)
Table 50. World Progesterone Injection Production Value by Type (2021-2026) & (USD Million)
Table 51. World Progesterone Injection Production Value by Type (2027-2032) & (USD Million)
Table 52. World Progesterone Injection Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Progesterone Injection Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Progesterone Injection Production Value by Formulation, (USD Million), 2021 & 2025 & 2032
Table 55. World Progesterone Injection Production by Formulation (2021-2026) & (K Units)
Table 56. World Progesterone Injection Production by Formulation (2027-2032) & (K Units)
Table 57. World Progesterone Injection Production Value by Formulation (2021-2026) & (USD Million)
Table 58. World Progesterone Injection Production Value by Formulation (2027-2032) & (USD Million)
Table 59. World Progesterone Injection Average Price by Formulation (2021-2026) & (US$/Unit)
Table 60. World Progesterone Injection Average Price by Formulation (2027-2032) & (US$/Unit)
Table 61. World Progesterone Injection Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Table 62. World Progesterone Injection Production by Clinical Indication (2021-2026) & (K Units)
Table 63. World Progesterone Injection Production by Clinical Indication (2027-2032) & (K Units)
Table 64. World Progesterone Injection Production Value by Clinical Indication (2021-2026) & (USD Million)
Table 65. World Progesterone Injection Production Value by Clinical Indication (2027-2032) & (USD Million)
Table 66. World Progesterone Injection Average Price by Clinical Indication (2021-2026) & (US$/Unit)
Table 67. World Progesterone Injection Average Price by Clinical Indication (2027-2032) & (US$/Unit)
Table 68. World Progesterone Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Progesterone Injection Production by Application (2021-2026) & (K Units)
Table 70. World Progesterone Injection Production by Application (2027-2032) & (K Units)
Table 71. World Progesterone Injection Production Value by Application (2021-2026) & (USD Million)
Table 72. World Progesterone Injection Production Value by Application (2027-2032) & (USD Million)
Table 73. World Progesterone Injection Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Progesterone Injection Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Besins Healthcare Basic Information, Manufacturing Base and Competitors
Table 76. Besins Healthcare Major Business
Table 77. Besins Healthcare Progesterone Injection Product and Services
Table 78. Besins Healthcare Progesterone Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Besins Healthcare Recent Developments/Updates
Table 80. Besins Healthcare Competitive Strengths & Weaknesses
Table 81. Organon Basic Information, Manufacturing Base and Competitors
Table 82. Organon Major Business
Table 83. Organon Progesterone Injection Product and Services
Table 84. Organon Progesterone Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Organon Recent Developments/Updates
Table 86. Organon Competitive Strengths & Weaknesses
Table 87. Pfizer Basic Information, Manufacturing Base and Competitors
Table 88. Pfizer Major Business
Table 89. Pfizer Progesterone Injection Product and Services
Table 90. Pfizer Progesterone Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Pfizer Recent Developments/Updates
Table 92. Pfizer Competitive Strengths & Weaknesses
Table 93. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 94. Sun Pharmaceutical Industries Major Business
Table 95. Sun Pharmaceutical Industries Progesterone Injection Product and Services
Table 96. Sun Pharmaceutical Industries Progesterone Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Sun Pharmaceutical Industries Recent Developments/Updates
Table 98. Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 99. Zydus Lifesciences Basic Information, Manufacturing Base and Competitors
Table 100. Zydus Lifesciences Major Business
Table 101. Zydus Lifesciences Progesterone Injection Product and Services
Table 102. Zydus Lifesciences Progesterone Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Zydus Lifesciences Recent Developments/Updates
Table 104. Zydus Lifesciences Competitive Strengths & Weaknesses
Table 105. Cipla Basic Information, Manufacturing Base and Competitors
Table 106. Cipla Major Business
Table 107. Cipla Progesterone Injection Product and Services
Table 108. Cipla Progesterone Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Cipla Recent Developments/Updates
Table 110. Cipla Competitive Strengths & Weaknesses
Table 111. Intas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 112. Intas Pharmaceuticals Major Business
Table 113. Intas Pharmaceuticals Progesterone Injection Product and Services
Table 114. Intas Pharmaceuticals Progesterone Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Intas Pharmaceuticals Recent Developments/Updates
Table 116. Intas Pharmaceuticals Competitive Strengths & Weaknesses
Table 117. Zhejiang Xianju Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 118. Zhejiang Xianju Pharmaceutical Major Business
Table 119. Zhejiang Xianju Pharmaceutical Progesterone Injection Product and Services
Table 120. Zhejiang Xianju Pharmaceutical Progesterone Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Zhejiang Xianju Pharmaceutical Recent Developments/Updates
Table 122. Zhejiang Xianju Pharmaceutical Competitive Strengths & Weaknesses
Table 123. Grand Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 124. Grand Pharmaceutical Group Major Business
Table 125. Grand Pharmaceutical Group Progesterone Injection Product and Services
Table 126. Grand Pharmaceutical Group Progesterone Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Grand Pharmaceutical Group Recent Developments/Updates
Table 128. Grand Pharmaceutical Group Competitive Strengths & Weaknesses
Table 129. Livzon Basic Information, Manufacturing Base and Competitors
Table 130. Livzon Major Business
Table 131. Livzon Progesterone Injection Product and Services
Table 132. Livzon Progesterone Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Livzon Recent Developments/Updates
Table 134. Livzon Competitive Strengths & Weaknesses
Table 135. Global Key Players of Progesterone Injection Upstream (Raw Materials)
Table 136. Global Progesterone Injection Typical Customers
Table 137. Progesterone Injection Typical Distributors
LIST OF FIGURES
Figure 1. Progesterone Injection Picture
Figure 2. World Progesterone Injection Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Progesterone Injection Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Progesterone Injection Production (2021-2032) & (K Units)
Figure 5. World Progesterone Injection Average Price (2021-2032) & (US$/Unit)
Figure 6. World Progesterone Injection Production Value Market Share by Region (2021-2032)
Figure 7. World Progesterone Injection Production Market Share by Region (2021-2032)
Figure 8. North America Progesterone Injection Production (2021-2032) & (K Units)
Figure 9. Europe Progesterone Injection Production (2021-2032) & (K Units)
Figure 10. China Progesterone Injection Production (2021-2032) & (K Units)
Figure 11. Japan Progesterone Injection Production (2021-2032) & (K Units)
Figure 12. Progesterone Injection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Progesterone Injection Consumption (2021-2032) & (K Units)
Figure 15. World Progesterone Injection Consumption Market Share by Region (2021-2032)
Figure 16. United States Progesterone Injection Consumption (2021-2032) & (K Units)
Figure 17. China Progesterone Injection Consumption (2021-2032) & (K Units)
Figure 18. Europe Progesterone Injection Consumption (2021-2032) & (K Units)
Figure 19. Japan Progesterone Injection Consumption (2021-2032) & (K Units)
Figure 20. South Korea Progesterone Injection Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Progesterone Injection Consumption (2021-2032) & (K Units)
Figure 22. India Progesterone Injection Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Progesterone Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Progesterone Injection Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Progesterone Injection Markets in 2025
Figure 26. United States VS China: Progesterone Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Progesterone Injection Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Progesterone Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Progesterone Injection Production Market Share 2025
Figure 30. China Based Manufacturers Progesterone Injection Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Progesterone Injection Production Market Share 2025
Figure 32. World Progesterone Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Progesterone Injection Production Value Market Share by Type in 2025
Figure 34. Originator Products
Figure 35. Branded Generics
Figure 36. World Progesterone Injection Production Market Share by Type (2021-2032)
Figure 37. World Progesterone Injection Production Value Market Share by Type (2021-2032)
Figure 38. World Progesterone Injection Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. World Progesterone Injection Production Value by Formulation, (USD Million), 2021 & 2025 & 2032
Figure 40. World Progesterone Injection Production Value Market Share by Formulation in 2025
Figure 41. Oil-based Intramuscular Injection
Figure 42. Other
Figure 43. World Progesterone Injection Production Market Share by Formulation (2021-2032)
Figure 44. World Progesterone Injection Production Value Market Share by Formulation (2021-2032)
Figure 45. World Progesterone Injection Average Price by Formulation (2021-2032) & (US$/Unit)
Figure 46. World Progesterone Injection Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Figure 47. World Progesterone Injection Production Value Market Share by Clinical Indication in 2025
Figure 48. Luteal Phase Support in Assisted Reproductive Technology
Figure 49. Treatment of Luteal Phase Deficiency
Figure 50. Others
Figure 51. World Progesterone Injection Production Market Share by Clinical Indication (2021-2032)
Figure 52. World Progesterone Injection Production Value Market Share by Clinical Indication (2021-2032)
Figure 53. World Progesterone Injection Average Price by Clinical Indication (2021-2032) & (US$/Unit)
Figure 54. World Progesterone Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 55. World Progesterone Injection Production Value Market Share by Application in 2025
Figure 56. Hospital
Figure 57. Clinic
Figure 58. Others
Figure 59. World Progesterone Injection Production Market Share by Application (2021-2032)
Figure 60. World Progesterone Injection Production Value Market Share by Application (2021-2032)
Figure 61. World Progesterone Injection Average Price by Application (2021-2032) & (US$/Unit)
Figure 62. Progesterone Injection Industry Chain
Figure 63. Progesterone Injection Procurement Model
Figure 64. Progesterone Injection Sales Model
Figure 65. Progesterone Injection Sales Channels, Direct Sales, and Distribution
Figure 66. Methodology
Figure 67. Research Process and Data Source
Figure 1. Progesterone Injection Picture
Figure 2. World Progesterone Injection Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Progesterone Injection Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Progesterone Injection Production (2021-2032) & (K Units)
Figure 5. World Progesterone Injection Average Price (2021-2032) & (US$/Unit)
Figure 6. World Progesterone Injection Production Value Market Share by Region (2021-2032)
Figure 7. World Progesterone Injection Production Market Share by Region (2021-2032)
Figure 8. North America Progesterone Injection Production (2021-2032) & (K Units)
Figure 9. Europe Progesterone Injection Production (2021-2032) & (K Units)
Figure 10. China Progesterone Injection Production (2021-2032) & (K Units)
Figure 11. Japan Progesterone Injection Production (2021-2032) & (K Units)
Figure 12. Progesterone Injection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Progesterone Injection Consumption (2021-2032) & (K Units)
Figure 15. World Progesterone Injection Consumption Market Share by Region (2021-2032)
Figure 16. United States Progesterone Injection Consumption (2021-2032) & (K Units)
Figure 17. China Progesterone Injection Consumption (2021-2032) & (K Units)
Figure 18. Europe Progesterone Injection Consumption (2021-2032) & (K Units)
Figure 19. Japan Progesterone Injection Consumption (2021-2032) & (K Units)
Figure 20. South Korea Progesterone Injection Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Progesterone Injection Consumption (2021-2032) & (K Units)
Figure 22. India Progesterone Injection Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Progesterone Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Progesterone Injection Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Progesterone Injection Markets in 2025
Figure 26. United States VS China: Progesterone Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Progesterone Injection Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Progesterone Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Progesterone Injection Production Market Share 2025
Figure 30. China Based Manufacturers Progesterone Injection Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Progesterone Injection Production Market Share 2025
Figure 32. World Progesterone Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Progesterone Injection Production Value Market Share by Type in 2025
Figure 34. Originator Products
Figure 35. Branded Generics
Figure 36. World Progesterone Injection Production Market Share by Type (2021-2032)
Figure 37. World Progesterone Injection Production Value Market Share by Type (2021-2032)
Figure 38. World Progesterone Injection Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. World Progesterone Injection Production Value by Formulation, (USD Million), 2021 & 2025 & 2032
Figure 40. World Progesterone Injection Production Value Market Share by Formulation in 2025
Figure 41. Oil-based Intramuscular Injection
Figure 42. Other
Figure 43. World Progesterone Injection Production Market Share by Formulation (2021-2032)
Figure 44. World Progesterone Injection Production Value Market Share by Formulation (2021-2032)
Figure 45. World Progesterone Injection Average Price by Formulation (2021-2032) & (US$/Unit)
Figure 46. World Progesterone Injection Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Figure 47. World Progesterone Injection Production Value Market Share by Clinical Indication in 2025
Figure 48. Luteal Phase Support in Assisted Reproductive Technology
Figure 49. Treatment of Luteal Phase Deficiency
Figure 50. Others
Figure 51. World Progesterone Injection Production Market Share by Clinical Indication (2021-2032)
Figure 52. World Progesterone Injection Production Value Market Share by Clinical Indication (2021-2032)
Figure 53. World Progesterone Injection Average Price by Clinical Indication (2021-2032) & (US$/Unit)
Figure 54. World Progesterone Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 55. World Progesterone Injection Production Value Market Share by Application in 2025
Figure 56. Hospital
Figure 57. Clinic
Figure 58. Others
Figure 59. World Progesterone Injection Production Market Share by Application (2021-2032)
Figure 60. World Progesterone Injection Production Value Market Share by Application (2021-2032)
Figure 61. World Progesterone Injection Average Price by Application (2021-2032) & (US$/Unit)
Figure 62. Progesterone Injection Industry Chain
Figure 63. Progesterone Injection Procurement Model
Figure 64. Progesterone Injection Sales Model
Figure 65. Progesterone Injection Sales Channels, Direct Sales, and Distribution
Figure 66. Methodology
Figure 67. Research Process and Data Source
